SP 3

DUH TUBUH URETRA PADA

LAKI-LAKI:
GONORRHEA
I Gusti Ayu Gita Devi Kusumastuti
1670121052
SGD 2
Introduction
 Caused by N gonorrhoeae
 2nd most common communicable disease in the US
 2nd most common STIs in North America
Risk Factors
 Sexual contact with new or multiple partners
 Sexual contact with an infected person
 Inconsistent condom use
 Sexual workers
 Low socioeconomic status
 Lack of education
Clinical Signs & Symptoms
 Dysuria
 Urethral discharge and itch
 Unilateral testicular swelling
 Testicular or rectal pain
Laboratory and Diagnostic Evaluation
 Gram stain
 Culture → can be obtained with urethral swab
 Nucleic Acid Amplification Test (NAAT)
Treatment
 Azithromycin
 Doxycycline
 Ceftriaxone
 Cefixime
Prevention and Management
Considerations
 Counseling high-risk patient
 Screening
 Use condom
 Partner of a patient with a gonococcal infection should
be referred for evaluation & probable treatment
 REFERENCES
 Morgan, M.K., Decker, C.F., 2016. Gonorrhea. Disease a Month. 62(8):260-
268
 Dalke, B., Ivers, T., O’Brien, K.K., Castillo, S., Hoie, E., Begley, K., 2016.
Gonorrhea Treatment and Management Considerations for The Male
Patient. US Pharmacy
 Piszczek, J., St. Jean, R., Khaliq, Y., 2015. Gonorrhea: Treatment update for
an increasingly resistant organism. CPJ/RPC. 148(2)
THANK YOU